ASCENTAGE PHARMA GROUP INTERNATIONAL
Last 30 daysNo qualifying insider buying. No qualifying insider sales.
Showing the first 6 of 25 trades on this page.
Chief Medical Officer
Ordinary Shares
The filing reports a zero transaction price. That is not a current market valuation; inspect the original filing for context.
Chief Medical Officer
Ordinary Shares
The filing reports a zero transaction price. That is not a current market valuation; inspect the original filing for context.
Chief Medical Officer
Restricted stock units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Medical Officer
Restricted stock units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Medical Officer
Options
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Medical Officer
Options
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Medical Officer
Restricted stock units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Medical Officer
Restricted stock units
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chief Medical Officer
Restricted stock units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Medical Officer
Restricted stock units
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chief Medical Officer
Restricted stock units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Medical Officer
Options
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chairman and CEO
Ordinary Shares
The filing reports a zero transaction price. That is not a current market valuation; inspect the original filing for context.
Chairman and CEO
Ordinary Shares
The filing reports a zero transaction price. That is not a current market valuation; inspect the original filing for context.
Chairman and CEO
Restricted stock units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chairman and CEO
Restricted stock units
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chairman and CEO
Restricted stock units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chairman and CEO
Options
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chairman and CEO
Restricted stock units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chairman and CEO
Restricted stock units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chairman and CEO
Options
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chairman and CEO
Options
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chairman and CEO
Restricted stock units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chairman and CEO
Restricted stock units
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chief Financial Officer
Restricted stock units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| Chief Medical Officer | Ordinary SharesOption exercise or conversion | 92,746$0 reported · see filing | Not established | May 21Filed May 22 · 1d later | SEC filing |
| Chief Medical Officer | Ordinary SharesOption exercise or conversion | 95,575$0 reported · see filing | Not established | May 21Filed May 22 · 1d later | SEC filing |
| Chief Medical Officer | Restricted stock unitsGrant or award | Derivative units103,365Award · no purchase price | Non-cash award | May 20Filed May 22 · 2d later | SEC filing |
| Chief Medical Officer | Restricted stock unitsGrant or award | Derivative units214,999Award · no purchase price | Non-cash award | May 20Filed May 22 · 2d later | SEC filing |
| Chief Medical Officer | OptionsGrant or award | Derivative units214,988Award · no purchase price | Non-cash award | May 20Filed May 22 · 2d later | SEC filing |
| Chief Medical Officer | OptionsGrant or award | Derivative units103,364Award · no purchase price | Non-cash award | May 20Filed May 22 · 2d later | SEC filing |
| Chief Medical Officer | Restricted stock unitsGrant or award | Derivative units92,746Award · no purchase price | Non-cash award | May 20Filed May 22 · 2d later | SEC filing |
| Chief Medical Officer | Restricted stock unitsOption exercise or conversion | Derivative units92,746$0.00 exercise / conversion price | Not a separate purchase | May 21Filed May 22 · 1d later | SEC filing |
| Chief Medical Officer | Restricted stock unitsGrant or award | Derivative units95,575Award · no purchase price | Non-cash award | May 20Filed May 22 · 2d later | SEC filing |
| Chief Medical Officer | Restricted stock unitsOption exercise or conversion | Derivative units95,575$0.00 exercise / conversion price | Not a separate purchase | May 21Filed May 22 · 1d later | SEC filing |
| Chief Medical Officer | Restricted stock unitsGrant or award | Derivative units298,195Award · no purchase price | Non-cash award | May 20Filed May 22 · 2d later | SEC filing |
| Chief Medical Officer | OptionsGrant or award | Derivative units298,194Award · no purchase price | Non-cash award | May 20Filed May 22 · 2d later | SEC filing |
| Chairman and CEO | Ordinary SharesOption exercise or conversion | 95,575$0 reported · see filing | Not established | May 21Filed May 22 · 1d later | SEC filing |
| Chairman and CEO | Ordinary SharesOption exercise or conversion | 92,746$0 reported · see filing | Not established | May 21Filed May 22 · 1d later | SEC filing |
| Chairman and CEO | Restricted stock unitsGrant or award | Derivative units95,575Award · no purchase price | Non-cash award | May 20Filed May 22 · 2d later | SEC filing |
| Chairman and CEO | Restricted stock unitsOption exercise or conversion | Derivative units95,575$0.00 exercise / conversion price | Not a separate purchase | May 21Filed May 22 · 1d later | SEC filing |
| Chairman and CEO | Restricted stock unitsGrant or award | Derivative units298,195Award · no purchase price | Non-cash award | May 20Filed May 22 · 2d later | SEC filing |
| Chairman and CEO | OptionsGrant or award | Derivative units298,194Award · no purchase price | Non-cash award | May 20Filed May 22 · 2d later | SEC filing |
| Chairman and CEO | Restricted stock unitsGrant or award | Derivative units103,365Award · no purchase price | Non-cash award | May 20Filed May 22 · 2d later | SEC filing |
| Chairman and CEO | Restricted stock unitsGrant or award | Derivative units214,999Award · no purchase price | Non-cash award | May 20Filed May 22 · 2d later | SEC filing |
| Chairman and CEO | OptionsGrant or award | Derivative units214,988Award · no purchase price | Non-cash award | May 20Filed May 22 · 2d later | SEC filing |
| Chairman and CEO | OptionsGrant or award | Derivative units103,364Award · no purchase price | Non-cash award | May 20Filed May 22 · 2d later | SEC filing |
| Chairman and CEO | Restricted stock unitsGrant or award | Derivative units92,746Award · no purchase price | Non-cash award | May 20Filed May 22 · 2d later | SEC filing |
| Chairman and CEO | Restricted stock unitsOption exercise or conversion | Derivative units92,746$0.00 exercise / conversion price | Not a separate purchase | May 21Filed May 22 · 1d later | SEC filing |
| Chief Financial Officer | Restricted stock unitsGrant or award | Derivative units18,584Award · no purchase price | Non-cash award | Apr 20Filed Apr 21 · 1d later | SEC filing |
This reflects the filings imported so far, not a complete trading history.
No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
